ACTIVE

MEDIPHARMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

94,3 k €

-36.9% YoY

Gross margin

149,8 k €

-37.4% YoY

Equity

2 M €

+4.8% YoY

What does MEDIPHARMA do?

MEDIPHARMA is a Private limited company incorporated in 2009. Its main activity is: Activities of holding companies. Its registered office is in Boortmeerbeek.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0821.792.314

Incorporation

10/12/2009

Legal form

Private limited company

Registered office

Leuvensesteenweg 22
3191 Boortmeerbeek · FlandreSee on map

Contributed capital

12 400,00 €

Latest accounts

31/12/2025

Activities (NACE)

64200Activities of holding companies· main 64210Activities of holding companies

Signals

ProfitableSolid equityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 13 financial years

	2025		2024		2023		2022		2021		2017		2016		2015		2014		2013		2012		2011		2010
Income statement
Gross margin	149,8 k €	-37.4%	239,1 k €	-13.6%	276,7 k €	+29.9%	213 k €	+13.0%	188,4 k €	-33.9%	285,2 k €	+123%	128,1 k €	-0.7%	129 k €	-2.8%	132,7 k €	+1.0%	131,5 k €	+2.1%	128,8 k €	-38.5%	209,5 k €	-1.4%	212,5 k €
EBITDA	148 k €	-37.5%	236,8 k €	-13.4%	273,6 k €	+31.6%	207,9 k €	+11.6%	186,4 k €	-33.7%	281,3 k €	+124%	125,3 k €	+1.3%	123,7 k €	-4.9%	130,1 k €	+0.2%	129,9 k €	+2.3%	126,9 k €	-39.2%	208,8 k €	-1.5%	211,9 k €
Operating result	147,5 k €	-35.7%	229,5 k €	-13.1%	264 k €	+28.9%	204,8 k €	+10.5%	185,3 k €	-34.1%	281,3 k €	+124%	125,3 k €	+1.5%	123,5 k €	-4.2%	128,9 k €	+0.6%	128,1 k €	+10.2%	116,2 k €	-41.4%	198,4 k €	-1.8%	202 k €
Net result	94,3 k €	-36.9%	149,3 k €	-14.0%	173,6 k €	+35.4%	128,2 k €	+15.7%	110,7 k €	-22.1%	142,1 k €	-55.0%	315,9 k €	+832%	33,9 k €	-25.8%	45,7 k €	+30.7%	34,9 k €	+61.2%	21,7 k €	-70.7%	74,1 k €	-83.7%	454,8 k €
Balance sheet
Equity	2 M €	+4.8%	2 M €	+8.3%	1,8 M €	+10.6%	1,6 M €	+8.5%	1,5 M €	+32.3%	1,1 M €	+14.3%	993,3 k €	+46.6%	677,4 k €	+5.3%	643,5 k €	+7.6%	597,9 k €	+6.2%	562,9 k €	+4.0%	541,2 k €	+15.9%	467,2 k €
Total assets	2,7 M €	+0.2%	2,7 M €	-0.4%	2,7 M €	-0.5%	2,7 M €	+0.6%	2,7 M €	-8.2%	3 M €	+9.2%	2,7 M €	+0.0%	2,7 M €	-0.1%	2,7 M €	+0.0%	2,7 M €	-1.8%	2,8 M €	+0.6%	2,7 M €	-2.0%	2,8 M €
Cash	1,8 k €		–		3,7 k €	+93.5%	1,9 k €	-72.6%	7 k €	-86.4%	51,6 k €	+1434%	3,4 k €	+58.0%	2,1 k €	-60.0%	5,3 k €		–		0 €	-100%	14,3 k €	-80.7%	74,3 k €
Debts	652,8 k €	-11.2%	735,3 k €	-18.8%	905,4 k €	-17.3%	1,1 M €	-9.0%	1,2 M €	-33.9%	1,8 M €	+6.4%	1,7 M €	-15.5%	2 M €	-1.9%	2,1 M €	-2.1%	2,1 M €	-3.7%	2,2 M €	-0.6%	2,2 M €	-5.5%	2,3 M €

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 4 ended

Active mandates

Ann Hendrix

Bestuurder

Active

Antoon Medaer

Bestuurder

Active

Ended mandates

Ann Hendrix

Director

Ended

ANN HENDRIX

Manager

Ended

Antoon Medaer

Director

Ended

ANTOON MEDAER

Manager

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	15/06/2026	17/06/2025	10/06/2024	27/06/2023	24/06/2022	18/06/2021
General meeting	13/06/2026	14/06/2025	08/06/2024	10/06/2023	11/06/2022	12/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

16 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	13/06/2026	15/06/2026	Dutch	PDF
Abridged model	31/12/2024	14/06/2025	17/06/2025	Dutch	PDF
Abridged model	31/12/2023	08/06/2024	10/06/2024	Dutch	PDF
Abridged model	31/12/2022	10/06/2023	27/06/2023	Dutch	PDF
Abridged model	31/12/2021	11/06/2022	24/06/2022	Dutch	PDF
Abridged model	31/12/2020	12/06/2021	18/06/2021	Dutch	PDF
Abridged model	31/12/2019	13/06/2020	03/07/2020	Dutch	PDF
Abridged model	31/12/2018	08/06/2019	03/07/2019	Dutch	PDF
Abridged model	31/12/2017	09/06/2018	07/08/2018	Dutch	PDF
Abridged model	31/12/2016	10/06/2017	03/08/2017	Dutch	PDF
Abridged model	31/12/2015	11/06/2016	22/06/2016	Dutch	PDF
Abridged model	31/12/2014	13/05/2015	01/07/2015	Dutch	PDF
Abridged model	31/12/2013	14/06/2014	30/06/2014	Dutch	PDF
Abridged model	31/12/2012	08/06/2013	01/07/2013	Dutch	PDF
Abridged model	31/12/2011	09/06/2012	23/06/2012	Dutch	PDF
Abridged model	31/12/2010	30/06/2011	12/07/2011	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 4 ended

Active mandates

Ann Hendrix

Bestuurder

Active

Antoon Medaer

Bestuurder

Active

Ended mandates

Ann Hendrix

Director

Ended

ANN HENDRIX

Manager

Ended

Antoon Medaer

Director

Ended

ANTOON MEDAER

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates13/07/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DIVERSEN - ONTSLAGEN - BENOEMINGEN
PDF
Registered office22/06/2010
MAATSCHAPPELIJKE ZETEL
PDF
Other07/01/2010
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202594,3 k €↓
2024
Annual accounts 2024149,3 k €↓
2023
Annual accounts 2023173,6 k €↑
2022
Annual accounts 2022128,2 k €↑
2021
Annual accounts 2021110,7 k €↓
2017
Annual accounts 2017142,1 k €↓
2016
Annual accounts 2016315,9 k €↑
2015
Annual accounts 201533,9 k €↓
2014
Annual accounts 201445,7 k €↑
2013
Annual accounts 201334,9 k €↑
2012
Annual accounts 201221,7 k €↓
2011
Annual accounts 201174,1 k €↓
2010
Annual accounts 2010454,8 k €
10/12/2009
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

MEDIPHARMA

Overview

What does MEDIPHARMA do?

Trend over 13 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline